603139.SS · 康惠股份
China A-shares · RS rating 71 · As of 2026-10-14
| Price | 33.87 CNY |
|---|---|
| 1-day change | -2.4% |
| RS rating (overall / 1M / 3M / 12M) | 71 / 34 / 25 / 92 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 38 / 34 / 18 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +19.9% |
| Distance from 52-week high | +25.1% |
| Market cap (USD) | $548.5M |